TriSalus Life Sciences Inc
TLSI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$166.15M
Close$
$-8.19
387.4% downside
Current Fair Value
387.4% downsideOvervalued by 387.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $166.15 Million |
|---|---|
| Enterprise Value | $154.28 Million |
| Earnings per Share | $-1.84 |
| Beta | 0.51 |
| Outstanding Shares | 58,296,711 |
Return
| Return on Equity | -895.80% |
|---|---|
| Return on Assets | -93.96% |
| Return on Invested Capital | -55.68% |
Valuation & Multiples
| P/E Ratio | -2.5 |
|---|---|
| PEG | -23.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.42 |
| Enterprise Value to EBIT | -5.4 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 5.26 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 10, 2026
EPS Estimate
$-0.13
Consensus analyst estimateRevenue Estimate
$14.02 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.71%▼ 33.80% |
|---|---|
| Total Invested | $9.33M▼ 90.62% |
| Investors Holding | 18▼ 63.00% |